Grown Rogue International (GRUSF) Total Non-Current Liabilities (2009 - 2026)

Grown Rogue International's (GRUSF) quarterly Total Non-Current Liabilities came in at $2.9 million in Q1 2026, down 89.49% year-on-year from $27.7 million in Q1 2025, and down 3.0% quarter-over-quarter from $3.0 million in Q4 2025.

Grown Rogue International (GRUSF) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

Grown Rogue International's Total Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $2.9 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 89.49% year-over-year to $2.9 million in Q1 2026; TTM through Mar 2026 was $2.9 million, a 89.49% decrease from a year earlier, with the FY2025 full-year figure at $3.0 million, down 51.78% from the prior year.
  • Total Non-Current Liabilities eased to $2.9 million in Q1 2026 per GRUSF's latest filing, from $3.0 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $19184167000.0 billion in Q2 2025 and bottomed at -$193195.5 in Q4 2024.
  • The 5-year median for Total Non-Current Liabilities is $2.9 million (2026), against an average of $2131576667.2 billion.
  • Across the five-year window, Total Non-Current Liabilities sank 134.47% in 2024 and jumped 1652.92% in 2025, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $715461.0 in 2022, then decreased by 21.67% to $560425.0 in 2023, then sank by 134.47% to -$193195.5 in 2024, then soared by 1652.92% to $3.0 million in 2025, then retreated by 3.0% to $2.9 million in 2026.
  • Per Business Quant, the three latest GRUSF Total Non-Current Liabilities figures stand at $2.9 million (Q1 2026), $3.0 million (Q4 2025), and $23005.2 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Grown Rogue International 99.97 Mn 92.67 Mn 3.96 Mn 2.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.91 Mn
Dec 31, 2025 3.00 Mn
Sep 30, 2025 23,005.21 Bn
Jun 30, 2025 19,184,167,000.00 Bn
Mar 31, 2025 27.68 Mn
Dec 31, 2024 -193,195.51
Dec 31, 2023 560,425.00
Oct 31, 2023 253,340.00
Oct 31, 2022 715,461.00
Oct 31, 2021 1.23 Mn
Oct 31, 2020 68,994.00
Aug 31, 2018 63,212.58
May 31, 2018 -572,977.84
Feb 28, 2018 -573,520.90
Nov 30, 2017 -558,401.76
Aug 31, 2017 -170,845.96
May 31, 2017 -2.10 Mn
Feb 28, 2017 -2.13 Mn
Nov 30, 2016 -2.09 Mn
Aug 31, 2016 -1.35 Mn